| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |